Table 1.
Summary of the included studies
Author | year | Journal | Modality | TP | FP | FN | TN | Sensitivity (95%CI) | Specificity (95% CI) | QUADAS |
---|---|---|---|---|---|---|---|---|---|---|
Stevens MH |
1985 |
Arch Otolaryngol Head Neck Surg |
CT |
5 |
1 |
1 |
9 |
83%(54-100%) |
90%(71-100%) |
9 |
Maremonti P |
1997 |
J Craniomaxillofac Surg |
CT |
6 |
0 |
6 |
12 |
50%(22-78%) |
100% |
7 |
Righi PD |
1997 |
Head Neck |
CT |
6 |
0 |
4 |
23 |
60%(30-90%) |
100% |
7 |
Byers RM |
1998 |
Head Neck |
CT |
2 |
2 |
9 |
12 |
18%(0-41%) |
86%(67-100%) |
5 |
Myers LL |
1998 |
Laryngoscope |
CT |
4 |
1 |
3 |
9 |
57%(21-94%) |
90%(71-100%) |
10 |
Takes RP |
1998 |
Int J Radiat Oncol Biol Phys |
CT |
14 |
3 |
12 |
35 |
54%(35-73%) |
92%(84-100%) |
11 |
Akoglu E |
2005 |
J Otolaryngol |
CT |
2 |
1 |
1 |
10 |
67%(13-100%) |
91%(74-100%) |
10 |
Wilson GR |
1994 |
Br J Plast Surg |
MRI |
11 |
14 |
0 |
13 |
100% |
48%(29-67%) |
11 |
Braams JW |
1995 |
J Nucl Med |
MRI |
3 |
2 |
2 |
5 |
60%(17-100%) |
71%(38-100%) |
7 |
Maremonti P |
1997 |
J Craniomaxillofac Surg |
MRI |
4 |
4 |
8 |
8 |
33%(7-60%) |
67%(40-93%) |
7 |
Yucel T |
1997 |
Acta Radiol |
MRI |
4 |
1 |
1 |
12 |
80%(45%-100%) |
92%(78-100%) |
10 |
Akoglu E |
2005 |
J Otolaryngol |
MRI |
2 |
1 |
1 |
10 |
67%(13-100%) |
91%(74-100%) |
10 |
Thomsen JB |
2005 |
Acta Radiol |
MRI |
5 |
4 |
9 |
52 |
36%(11-61%) |
93%(86-100%) |
7 |
Braams JW |
1995 |
J Nucl Med |
PET |
5 |
2 |
0 |
5 |
100% |
71%(38-100%) |
7 |
Myers LL |
1998 |
J Otolaryngol |
PET |
7 |
0 |
0 |
4 |
100% |
100% |
10 |
Myers LL |
1998 |
Laryngoscope |
PET |
7 |
0 |
2 |
15 |
78%(51-100%) |
100% |
10 |
Kau RJ |
2002 |
Arch Otolaryngol Head Neck Surg |
PET |
1 |
1 |
4 |
6 |
20%(0-55%) |
86%(60-100%) |
13 |
Brouwer J |
2004 |
Eur Arch Otorhinolaryngol |
PET |
2 |
1 |
1 |
11 |
67%(13-100%) |
92%(76-100%) |
9 |
Akoglu E |
2005 |
J Otolaryngol |
PET |
2 |
1 |
1 |
10 |
67%(13-100%) |
91%(74-100%) |
10 |
Schoder H |
2006 |
J Nucl Med |
PET |
6 |
4 |
3 |
23 |
67%(36-98%) |
85%(72-99%) |
10 |
Wensing BM |
2006 |
Laryngoscope |
PET |
3 |
4 |
5 |
16 |
38%(4-71%) |
80%(63-98%) |
11 |
Iyer NG |
2010 |
Head Neck |
PET |
15 |
4 |
14 |
113 |
52%(34-70%) |
97%(93%-100%) |
12 |
Liao CT |
2010 |
J Nucl Med |
PET |
26 |
66 |
33 |
143 |
55%(31-57%) |
68%(62-75%) |
13 |
Richard C |
2010 |
Arch Otolaryngol Head Neck Surg |
PET |
7 |
5 |
1 |
8 |
88%(65-100%) |
62%(35-88%) |
11 |
van den Brekel MW |
1993 |
Eur Arch Otorhinolaryngol |
US |
21 |
13 |
15 |
39 |
58%(42-74%) |
75%(63-87%) |
9 |
Maremonti P |
1997 |
J Craniomaxillofac Surg |
US |
8 |
1 |
4 |
11 |
67%(40-93%) |
92%(76-100%) |
7 |
Righi PD |
1997 |
Head Neck |
US |
6 |
5 |
4 |
18 |
60%(30-90%) |
78%(61-95%) |
7 |
Byers RM |
1998 |
Head Neck |
US |
3 |
4 |
8 |
10 |
27%(1-54%) |
71%(48-95%) |
5 |
Takes RP |
1998 |
Int J Radiat Oncol Biol Phys |
US |
18 |
11 |
8 |
27 |
69%(52-87%) |
71%(57-86%) |
11 |
Hodder SC |
2000 |
Br J Oral Maxillofac Surg |
US |
9 |
4 |
3 |
17 |
75%(51-100%) |
81%(64-98%) |
7 |
Akoglu E |
2005 |
J Otolaryngol |
US |
3 |
4 |
0 |
7 |
100% |
64%(35-92%) |
10 |
Thomsen JB | 2005 | Acta Radiol | US | 13 | 10 | 2 | 55 | 87%(70-100%) | 85%(76-93%) | 7 |
TP: true positive; FP: false positive; FN: false negative; FP: false positive.
QUADAS: Quality Assessment of Diagnostic Accuracy Studies.
Sensitivities and specificities with 95% confidence interval (CI) values were reported for individual studies.